10,11-Dihydrocarbamazepine structure
|
Common Name | 10,11-Dihydrocarbamazepine | ||
|---|---|---|---|---|
| CAS Number | 3564-73-6 | Molecular Weight | 238.28 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 394.5±52.0 °C at 760 mmHg | |
| Molecular Formula | C15H14N2O | Melting Point | 205-210ºC | |
| MSDS | Chinese USA | Flash Point | 192.4±30.7 °C | |
| Symbol |
GHS07, GHS08 |
Signal Word | Danger | |
Use of 10,11-Dihydrocarbamazepine10,11-Dihydrocarbamazepine is the active metabolite of Oxcarbazepine. 10,11-Dihydrocarbamazepine also is an intermediate. Oxcarbazepine is rapidly and almost completely converted to 10,11-Dihydrocarbamazepine with probable Anticonvulsant efficacy[1]. |
| Name | 5,6-dihydrobenzo[b][1]benzazepine-11-carboxamide |
|---|---|
| Synonym | More Synonyms |
| Description | 10,11-Dihydrocarbamazepine is the active metabolite of Oxcarbazepine. 10,11-Dihydrocarbamazepine also is an intermediate. Oxcarbazepine is rapidly and almost completely converted to 10,11-Dihydrocarbamazepine with probable Anticonvulsant efficacy[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Oxcarbazepine is metabolized in the liver to its active metabolite, 10,11-Dihydrocarbamazepine. Oxcarbazepine is an antiepileptic drug (AED) used to treat partial seizures as a monotherapy or adjunctive therapy[1]. 10,11-Dihydrocarbamazepine may be used as a reference standard for the determination of 10,11-dihydrocarbamazepine in pharmaceutical formulations by liquid chromatography (LC)[1]. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 394.5±52.0 °C at 760 mmHg |
| Melting Point | 205-210ºC |
| Molecular Formula | C15H14N2O |
| Molecular Weight | 238.28 |
| Flash Point | 192.4±30.7 °C |
| Exact Mass | 238.110611 |
| PSA | 46.33000 |
| LogP | 2.60 |
| Vapour Pressure | 0.0±0.9 mmHg at 25°C |
| Index of Refraction | 1.645 |
| Storage condition | Refrigerator |
| Water Solubility | dichloromethane: soluble2.5%, clear, colorless | Soluble in dichloromethane. Insoluble in water. |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS07, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H302-H317-H334 |
| Precautionary Statements | P261-P280-P342 + P311 |
| Hazard Codes | Xn |
| Risk Phrases | 22-42/43 |
| Safety Phrases | S24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | HN8300000 |
| HS Code | 2933990090 |
|
~84%
10,11-Dihydroca... CAS#:3564-73-6 |
| Literature: Shamshin, V. P.; Voronin, V. G.; Borisov, M. M.; Mufazalova, T. P. Pharmaceutical Chemistry Journal, 1987 , vol. 21, # 6 p. 443 - 448 Khimiko-Farmatsevticheskii Zhurnal, 1987 , vol. 21, # 6 p. 711 - 716 |
|
~85%
10,11-Dihydroca... CAS#:3564-73-6 |
| Literature: Dunnbier; Jugelt Pharmazie, 1991 , vol. 46, # 7 p. 512 - 517 |
|
~%
10,11-Dihydroca... CAS#:3564-73-6 |
| Literature: Pharmaceutical Chemistry Journal, , vol. 21, # 6 p. 443 - 448 Khimiko-Farmatsevticheskii Zhurnal, , vol. 21, # 6 p. 711 - 716 |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Structure-activity relationship and site of binding of polyamine derivatives at the nicotinic acetylcholine receptor.
Eur. J. Biochem. 267(1) , 110-20, (2000) Several wasp venoms contain philanthotoxins (PhTXs), natural polyamine amides, which act as noncompetitive inhibitors (NCIs) on the nicotinic acetylcholine receptor (nAChR). Effects of varying the str... |
|
|
Liquid chromatographic methods for assay of carbamazepine, 10,11-dihydrocarbamazepine, and related compounds in carbamazepine drug substance and tablets.
J. Assoc. Off. Anal. Chem. 70(5) , 836-40, (1987) Liquid chromatographic (LC) methods have been developed for the determination of carbamazepine, the impurity 10,11-dihydrocarbamazepine, and related compounds in carbamazepine drug substance and table... |
|
|
An orthorhombic polymorph of 10,11-dihydrocarbamazepine.
Acta Crystallogr. C 62(Pt 5) , o240-2, (2006) The title compound (systematic name: 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide), C15H14N2O, is shown to crystallize as an orthorhombic polymorph to complement the known monoclinic form. The mo... |
| 10,11-dihydro-5-carboxamido-5H-dibenz<b,f>azepine |
| 10,11-Dihydro-5-carbamoyl-5H-dibenz<b,f>azepin |
| 10,11-Dihydro-5-carbamoyl-5H-dibenz<b,f>azepine |
| GP 26-301 |
| 10,11-DIHYDROCARBAMAZEPINE |
| EINECS 222-649-0 |
| 10,11-Dihydro-5H-dibenz[b,f]azepine-5-carboxamide |
| 10,11-Dihydrocarbamazepine,10,11-Dihydro-5H-dibenz[b,f]azepine-5-carboxamide |
| MFCD00005072 |
| 10,11-Dihydro-5H-dibenz(b,f)azepine-5-carboxamide |
| 10,11-Dihydro-5H-dibenzo[b,f]azepine-5-carboxamide |
| 5H-DIBENZ(b,f)AZEPINE-5-CARBOXAMIDE,10,11-DIHYDRO |
| 5H-Dibenz[b,f]azepine-5-carboxamide, 10,11-dihydro- |